UnitedHealthcare and Cigna Coverage for Cleerly LABS Advanced Plaque Analysis Begins October 1st
Major Payors Embrace AI-Powered Cardiac Imaging, Expanding Access to Advanced Plaque Analysis
Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.
Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.
Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.
For any questions, please reach out to press@cleerlyhealth.com
Major Payors Embrace AI-Powered Cardiac Imaging, Expanding Access to Advanced Plaque Analysis
Major Insurer Joins UnitedHealthcare in Covering Cleerly's AI-QCT/AI-CPA Technology, Expanding Access to 61 Million Americans
AI-powered coronary assessment provides incremental prognostic value over traditional visual assessment methods for predicting major adverse...
Leading Radiology Benefit Manager Recommends Positive Coverage for AI-QCT, Expanding Access to Advanced Cardiac Imaging Technology